# Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses

> **NCT02289768** · PHASE3 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 166 (actual)

## Conditions studied

- Actinic Keratosis

## Interventions

- **DRUG:** 5-fluorouracil/salicylic acid
- **DRUG:** Vehicle

## Key facts

- **NCT ID:** NCT02289768
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-10
- **Primary completion:** 2015-09
- **Final completion:** 2015-09
- **Target enrollment:** 166 (ACTUAL)
- **Last updated:** 2016-08-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02289768

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02289768, "Study To Evaluate The Efficacy And Safety Of Actikerall® Solution In Patients With Grade I-II Actinic Keratoses". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02289768. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*